AVAI Bio, Inc. (AVAI) stock
AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)
Close on Oct 19, 2026Market cap $17.24MP/E –Yield –
AVAI Bio r&d expenses
Research and development expenses are spending on new products and technology.
AVAI Bio's R&D Expenses for the twelve months ending Mar 31, 2020 was $27.04K. For fiscal 2026 it was $15.00K, down 44.5% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $15.00K | -44.5% |
| FY2020 | Mar 31, 2020 | $27.04K | – |
| FY2019 | Mar 31, 2019 | $0 | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $23.80K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $0 | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $0 | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $0 | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $0 | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $0 | – |
See a number that looks wrong?